Syndax Pharmaceuticals
Highly Engaged Employees
Manufacturing · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
730 3rd Ave Fl 9, New York, New York, 10...Phone Number
(781) 419-1400Website
www.syndax.comRevenue
$252.3 MillionStock Symbol
SNDXIndustry
About Syndax Pharmaceuticals
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for people living with cancer. The company specializes in targeted treatments for areas of significant unmet medical need, including acute leukemia and chronic graft-versus-host disease. Its portfolio includes approved therapies as well as additional clinical programs exploring broader applications and treatment combinations. Syndax combines drug discovery, clinical development, regulatory expertise, and commercial capabilities to advance oncology medicines from research through patient access. The company works with healthcare professionals, researchers, patients, and industry partners to improve cancer treatment and support meaningful patient outcomes.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SNDXShow moreSyndax Pharmaceuticals Org Chart
Compare Similar Companies to Syndax Pharmaceuticals
Compare insights from companies similar to Syndax Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Syndax Pharmaceuticals Tech Stack
A closer look at the technologies used by Syndax Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Syndax Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for people living with cancer. The company specializes in targeted treatments for areas of significant unmet medical need, including acute leukemia and chronic graft-versus-host disease. Its portfolio includes approved th... Read More